Cargando…
COVID-19 en pediatría: valoración crítica de la evidencia
We present the summary of a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology. The document tries to provide answers to a series of structured clinical questions, with an explicit definition of the populatio...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asociación Española de Pediatría. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173476/ http://dx.doi.org/10.1016/j.anpedi.2021.05.019 |
_version_ | 1783702730660904960 |
---|---|
author | González Rodríguez, Paz Pérez-Moneo Agapito, Begoña Albi Rodríguez, María Salomé Aizpurua Galdeano, Pilar Aparicio Rodrigo, María Fernández Rodríguez, María Mercedes Esparza Olcina, María Jesús Ochoa Sangrador, Carlos |
author_facet | González Rodríguez, Paz Pérez-Moneo Agapito, Begoña Albi Rodríguez, María Salomé Aizpurua Galdeano, Pilar Aparicio Rodrigo, María Fernández Rodríguez, María Mercedes Esparza Olcina, María Jesús Ochoa Sangrador, Carlos |
author_sort | González Rodríguez, Paz |
collection | PubMed |
description | We present the summary of a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology. The document tries to provide answers to a series of structured clinical questions, with an explicit definition of the population, intervention/exposure, comparison and outcome, and a rating of the clinical relevance of the outcome measures. We conducted a systematic review of the literature to answer the questions, grouped into six chapters: epidemiology, clinical practice, diagnosis, treatment, prevention, and vaccination. We assessed the risk of bias of the selected studies with standard instruments (RoB-2, ROBINS-I, QUADAS and Newcastle-Ottawa). We constructed evidence tables and, when necessary and possible, meta-analysis of the of the most relevant outcome measures. We followed the GRADE system to synthesize the evidence, assessing its quality, and, when appropriate, giving recommendations, rated according to the quality of the evidence, the values and preferences, the balance between benefits, risks and costs, equity and feasibility. |
format | Online Article Text |
id | pubmed-8173476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Asociación Española de Pediatría. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81734762021-06-03 COVID-19 en pediatría: valoración crítica de la evidencia González Rodríguez, Paz Pérez-Moneo Agapito, Begoña Albi Rodríguez, María Salomé Aizpurua Galdeano, Pilar Aparicio Rodrigo, María Fernández Rodríguez, María Mercedes Esparza Olcina, María Jesús Ochoa Sangrador, Carlos An Pediatr (Barc) Asociación Española de Pediatría We present the summary of a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology. The document tries to provide answers to a series of structured clinical questions, with an explicit definition of the population, intervention/exposure, comparison and outcome, and a rating of the clinical relevance of the outcome measures. We conducted a systematic review of the literature to answer the questions, grouped into six chapters: epidemiology, clinical practice, diagnosis, treatment, prevention, and vaccination. We assessed the risk of bias of the selected studies with standard instruments (RoB-2, ROBINS-I, QUADAS and Newcastle-Ottawa). We constructed evidence tables and, when necessary and possible, meta-analysis of the of the most relevant outcome measures. We followed the GRADE system to synthesize the evidence, assessing its quality, and, when appropriate, giving recommendations, rated according to the quality of the evidence, the values and preferences, the balance between benefits, risks and costs, equity and feasibility. Asociación Española de Pediatría. Published by Elsevier España, S.L.U. 2021-09 2021-06-03 /pmc/articles/PMC8173476/ http://dx.doi.org/10.1016/j.anpedi.2021.05.019 Text en © 2021 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Asociación Española de Pediatría González Rodríguez, Paz Pérez-Moneo Agapito, Begoña Albi Rodríguez, María Salomé Aizpurua Galdeano, Pilar Aparicio Rodrigo, María Fernández Rodríguez, María Mercedes Esparza Olcina, María Jesús Ochoa Sangrador, Carlos COVID-19 en pediatría: valoración crítica de la evidencia |
title | COVID-19 en pediatría: valoración crítica de la evidencia |
title_full | COVID-19 en pediatría: valoración crítica de la evidencia |
title_fullStr | COVID-19 en pediatría: valoración crítica de la evidencia |
title_full_unstemmed | COVID-19 en pediatría: valoración crítica de la evidencia |
title_short | COVID-19 en pediatría: valoración crítica de la evidencia |
title_sort | covid-19 en pediatría: valoración crítica de la evidencia |
topic | Asociación Española de Pediatría |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173476/ http://dx.doi.org/10.1016/j.anpedi.2021.05.019 |
work_keys_str_mv | AT gonzalezrodriguezpaz covid19enpediatriavaloracioncriticadelaevidencia AT perezmoneoagapitobegona covid19enpediatriavaloracioncriticadelaevidencia AT albirodriguezmariasalome covid19enpediatriavaloracioncriticadelaevidencia AT aizpuruagaldeanopilar covid19enpediatriavaloracioncriticadelaevidencia AT apariciorodrigomaria covid19enpediatriavaloracioncriticadelaevidencia AT fernandezrodriguezmariamercedes covid19enpediatriavaloracioncriticadelaevidencia AT esparzaolcinamariajesus covid19enpediatriavaloracioncriticadelaevidencia AT ochoasangradorcarlos covid19enpediatriavaloracioncriticadelaevidencia AT covid19enpediatriavaloracioncriticadelaevidencia |